Skip to content

The clinical observation of layered drainage during breast conserving surgery combined with local tissue flap repair

The clinical observation of layered drainage during breast conserving surgery combined with local tissue flap repair

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052177
Enrollment
Unknown
Registered
2021-10-20
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

case series:No

Sponsors

Yunnan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The patient is female, aged >=18 years; 2. ECOG score 0-1 points; 3. Unilateral or bilateral primary breast cancer confirmed by histopathology; 4. The patient must undergo breast conserving surgery and local tissue flap repair; 5. Indwelling one or more drainage tubes during the operation; 6. Those who have complete records of postoperative drainage information and are eligible for follow-up; 7. The heart, brain, lung, liver, kidney and other important organs have no major diseases; 8. Preoperative bone scan, CT, color Doppler ultrasound etc. to check the signs of distant metastasis.

Exclusion criteria

Exclusion criteria: 1. Those who have not undergone breast conserving surgery for breast cancer or who have not undergone local tissue flap repair during surgery; 2. Intraoperative radiotherapy; 3. Those with major diseases of the heart, brain, lung, liver, kidney and other important organs; 4. Preoperative bone scan, CT, color Doppler ultrasound and other examinations suggest that there are signs of distant metastasis; 5. Patients with active mental system diseases (schizophrenia, major depressive disorder, bipolar affective disorder, etc.); 6. Active connective tissue disease, such as scleroderma, systemic lupus erythematosus or collagen vascular disease; 7. Those who are unwilling to sign the informed consent; 8. Those without full capacity for civil conduct; 9. In the investigator's opinion, other conditions make them unsuitable for this trial.

Design outcomes

Primary

MeasureTime frame
Postoperative drainage volume;Disconnecting time;Incidence of complicationIs;

Countries

China

Contacts

Public ContactChen Wenlin

Yunnan Cancer Hospital

chenwenlin@aliyun.com+86 13888087395

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026